Matches in Library of Congress for { <http://lccn.loc.gov/2011046215> ?p ?o. }
Showing items 1 to 22 of
22
with 100 items per page.
- 2011046215 contributor B12154150.
- 2011046215 created "2012.".
- 2011046215 date "2012".
- 2011046215 date "2012.".
- 2011046215 dateCopyrighted "2012.".
- 2011046215 description "Includes bibliographical references and index.".
- 2011046215 description "Machine generated contents note: History of CNS drug development / Sheldon H. Preskorn -- Regulatory issues / Gwen L. Zornberg -- Pre-clinical development / Alan J. Cross and Frank D. Yocca -- Phase I trials: from traditional to newer approaches / Matthew Macaluso, Michael Krams and Sheldon H. Preskorn -- Phase II development and the path to personalized medicine in CNS disease / Douglas E. Feltner and Kenneth R. Evans -- CNS drug development - Phase III / Judith Dunn, Penny Randall and Amir Kalali / Statistics issues relevant to CNS drug development / Craig H. Mallinckrodt, William R. Prucka and Geert Molenberghs -- Clinical trials management at company level / Nuala Murphy -- Clinical trials management at the site level / Joseph Kwentus -- Medical writing for CNS indications / Ginette Nachman -- Dissemination of clinical trial information: multiple audiences, multiple formats / Leslie Citrome -- The importance of treating cognition in schizophrenia and other severe mental illnesses: background, strategies, and findings to date / Philip D. Harvey and Richard S. E. Keefe -- Leveraging disruptive technologies to drive innovation in CNS clinical drug development / Penny Randall, Judith Dunn and Amir Kalali.".
- 2011046215 extent "p. ;".
- 2011046215 identifier "9780521766067 (hardback)".
- 2011046215 issued "2012".
- 2011046215 issued "2012.".
- 2011046215 language "eng".
- 2011046215 publisher "Cambridge : Cambridge University Press,".
- 2011046215 subject "615.1/9 23".
- 2011046215 subject "Central Nervous System Agents pharmacology.".
- 2011046215 subject "Clinical Trials as Topic methods.".
- 2011046215 subject "Drug Evaluation methods.".
- 2011046215 subject "Drug Evaluation, Preclinical methods.".
- 2011046215 subject "QV 76.5".
- 2011046215 tableOfContents "Machine generated contents note: History of CNS drug development / Sheldon H. Preskorn -- Regulatory issues / Gwen L. Zornberg -- Pre-clinical development / Alan J. Cross and Frank D. Yocca -- Phase I trials: from traditional to newer approaches / Matthew Macaluso, Michael Krams and Sheldon H. Preskorn -- Phase II development and the path to personalized medicine in CNS disease / Douglas E. Feltner and Kenneth R. Evans -- CNS drug development - Phase III / Judith Dunn, Penny Randall and Amir Kalali / Statistics issues relevant to CNS drug development / Craig H. Mallinckrodt, William R. Prucka and Geert Molenberghs -- Clinical trials management at company level / Nuala Murphy -- Clinical trials management at the site level / Joseph Kwentus -- Medical writing for CNS indications / Ginette Nachman -- Dissemination of clinical trial information: multiple audiences, multiple formats / Leslie Citrome -- The importance of treating cognition in schizophrenia and other severe mental illnesses: background, strategies, and findings to date / Philip D. Harvey and Richard S. E. Keefe -- Leveraging disruptive technologies to drive innovation in CNS clinical drug development / Penny Randall, Judith Dunn and Amir Kalali.".
- 2011046215 title "Essential CNS drug development / edited by Amir Kalali ... [et al.].".
- 2011046215 type "text".